KBLI 21013: Animal Pharmaceutical Industry

KBLI 21013: Animal Pharmaceutical Industry · Open to PMA

§ 01

Foreign investment rules

Indonesia's BUPM (Investment Business Fields) regulation places this code into one of five tracks. The track determines whether a foreign investor (PMA) can operate in this activity at all, and under what conditions.

Status · open

Open under BUPM (subject to sector rules)

KBLI 21013 is not on Indonesia's closed, conditional, SME-reserved, or partnership-required schedules under BUPM (Pres. Reg. 10/2021). A foreign investor can incorporate a PT PMA under this code, but sector regulators (PSE/Kominfo, BPOM, OJK, Kemenkes, Permendag, ESDM) almost always add licensing and capital requirements on top — the practical answer depends on your specific business model.

This KBLI is open under BUPM (Pres. Reg. 10/2021) — it's not on any restricted, closed, SME-reserved, or partnership-required schedule. That's the BUPM verdict only, not a complete sector-readiness check: sector regulators almost always add requirements on top (PSE/Kominfo for digital platforms, BPOM for food and cosmetics, OJK for financial, Kemenkes for healthcare, Permendag for retail, ESDM for energy). BKPM's default capital floor is IDR 2.5 billion paid-up with IDR 10 billion+ total investment commitment per KBLI, but sector regulators frequently set higher minimums for specific activities. The practical answer depends on your business model — confirm with our team before committing capital.

Tax incentives

Foreign-investor tax benefits available for this KBLI under PMK 130/2020 (Tax Holiday) and PP 78/2019 (Tax Allowance). Both require approval — see the linked guide for the application path.

Eligible for Tax Allowance

30% reduction of taxable net income over 6 years, accelerated depreciation, 10-year loss carryforward. Mutually exclusive with Tax Holiday.

Note. Pharmaceutical manufacturing (KBLI 21xxx) is on the PP 78/2019 Tax Allowance priority list.

Sector capital requirement

Higher minimum capital required by BPOM / Kemenkes

Pharmaceutical manufacturing (CPOB facilities)

Required paid-up

No fixed minimum, but GMP-compliant facility build typically IDR 50-100 billion+

Regulation

PMK 26/2018 (Pelayanan Perizinan Berusaha Terintegrasi Sektor Kesehatan)

Note. CPOB certification is the binding gate, not a flat capital number — meaningful capex needed for clean-room facility build.

BKPM Reg. 5/2025's default is IDR 2.5 billion paid-up + IDR 10 billion commitment per KBLI. The figure above is the binding override for this activity — the higher number wins.

§ 02

Regulations governing KBLI 21013

Current status, what each regulation actually requires for this activity, and how it ties to the PB UMKU sector permits below. Click through for the plain-English summary.

House of Representatives of the Republic of Indonesia
Indonesia, Kementerian Kesehatan
Indonesia, Kementerian Kesehatan

§ 03

How we handle your KBLI 21013 setup

Emerhub is a corporate-services provider in Indonesia. We do the legal and regulatory legwork for foreign investors so you can focus on the business itself. Here's what the engagement looks like.

1
Confirm the optimal structure for your business
2–3 business days
We confirm KBLI 21013 is the right primary code for your business, advise on secondary codes you may also need, and finalize the holding structure with you before any filing.
What we need from you
- Founders' passport copies and proof of residence
- Intended share split and board composition
2
Incorporate your PT PMA
7–10 business days
We draft the Articles of Association before a notary, register the entity with the Ministry of Law & Human Rights (Kemenkumham), and obtain the company's tax ID (NPWP). Under BKPM Reg. 5/2025, paid-up capital is IDR 2.5 billion (~USD 160K) — the cash actually deposited at incorporation. The IDR 10 billion+ figure many sources still cite is the total investment commitment per KBLI, realised over time via your LKPM reports.

Get an exact quote and timeline for KBLI 21013, scoped to your specific business plan.

Request a quote

§ 06

Licensing requirements in detail

Specific permits, application requirements and ongoing obligations vary by business scale and the sub-activity within this KBLI. We file these on your behalf — this section is for transparency on what we'll be handling. Switch between scales below; by default we show Large (the PMA scale).

What's required to operate

NIB

Preparation only — additional permit needed below

Standard Certificate (Self-declared)

Important: NIB is issued for the preparation stage. To begin commercial operations, the operator must self-declare compliance with applicable standards via OSS, which generates the Sertifikat Standar. Operating commercially with NIB alone is not legally compliant at this risk level.

Application requirements

Documents and capabilities you must demonstrate at registration

No specific application requirements at this scale.

Ongoing obligations

Compliance and reporting duties throughout operation

01Have proof of submission of mandatory validated Industrial Data every 6 (six) months in accordance with the laws and regulations in the industrial sector.
02Ensure the safety and security of equipment, processes, production results, storage, and transportation, in accordance with applicable laws and regulations.
03Having a customer complaint/product service for: a. Adverse events b. Product quality that demonstrates a minimum service commitment to customers.
04Possess periodic calibration documents for quality control equipment or periodic results from independent laboratory tests on the produced products.
05Have a document in the form of a disaster evacuation SOP, including the arrangement of workplace safety signs.
06Possess a Quality Management System certificate (ISO 9001).
07Have a safety and security SOP for: a. Storage of raw materials in the form of chemicals b. Use of machines/equipment c. Production processes

Issuing authority

The authority that issues the license depends on your situation.

Authority	Applies when
Minister/Head of Agency	The industrial location is situated within a cross-border area between provinces.
Minister/Head of Agency	Foreign Investment
Governor	The industrial location is in the relevant province.

§ 05

Auxiliary permits (PB UMKU)

PB UMKU permits sit on top of the main NIB and Sertifikat Standar — each is issued by a different ministry, and only when a specific operational activity is performed. This KBLI carries 5 candidate permits across 2 regulators; most operations only need a handful. Emerhub maps your operation to the exact set, files them, and tracks renewals.

Marine & Fisheries

3 permits

Ministry of Marine Affairs & Fisheries (KKP). Applies to capture fishing, aquaculture, fish processing, fish-feed production, and live-fish trade. The Processing Feasibility Certificate (SKP) is the gating quality permit for fish processors.

Veterinary & Animal Medicine

2 permits

Ministry of Agriculture. Applies if you produce, import, distribute, or sell animal medicines, vaccines, or feed; if you breed livestock; or if you operate a veterinary practice. A "veterinary control number" (NKV) is the entry-point permit for animal-product processors.

Speak to Emerhub

Get your KBLI 21013 setup handled end-to-end.

Emerhub is a corporate-services provider in Indonesia. We handle PT PMA incorporation, licensing, tax registration and monthly compliance — so you focus on operating the business.

Get a quote for KBLI 21013

§ 08

Common questions about KBLI 21013

What is KBLI 21013?

KBLI 21013 (Pharmaceutical Products for Animals) is the 5-digit Indonesian Standard Industrial Classification code for animal pharmaceutical industry. It sits within the Manufacturing Industry category in the official KBLI 2020 taxonomy maintained by Badan Pusat Statistik (BPS).

Can foreign investors operate under KBLI 21013?

KBLI 21013 is open to PT PMA under BUPM (Pres. Reg. 10/2021) — it is not on the closed, conditional, SME-reserved, or partnership-required schedules. That is the BUPM verdict only: sector regulators (PSE/Kominfo for digital platforms, BPOM for food and cosmetics, OJK for financial, Kemenkes for healthcare, Permendag for retail, ESDM for energy) commonly add licensing and capital requirements on top depending on the specific business model. Confirm the practical setup with our team before committing capital.

What is the risk level of KBLI 21013?

KBLI 21013's risk levels per business scale: Micro Medium-Low, Small Medium-Low, Medium Medium-Low, Large Medium-Low. Foreign-owned entities (PT PMA) must register at the Large scale.

What licenses does KBLI 21013 require?

NIB + self-declared Standard Certificate (Sertifikat Standar). KBLI 21013 is Medium-Low risk at Large scale, so the investor declares compliance with the applicable technical standard at NIB issuance. No government pre-audit, but the declaration is binding and can trigger a post-audit. 5 sector-specific PB UMKU permits also apply depending on the exact activity. See the requirements summary at the top of the page.

What is the minimum capital for a PT PMA under KBLI 21013?

Sector regulator override: No fixed minimum, but GMP-compliant facility build typically IDR 50-100 billion+ required by BPOM / Kemenkes under PMK 26/2018 (Pelayanan Perizinan Berusaha Terintegrasi Sektor Kesehatan). This is higher than BKPM Reg. 5/2025's default IDR 2.5 billion paid-up; the higher number wins.

How long does it take to register a business under KBLI 21013?

PT PMA setup typically takes 4-8 weeks end-to-end: AHU registration, NIB via OSS, bank account opening. KBLI-specific licensing depends on the permit instrument required.

Is KBLI 21013 eligible for Indonesian tax incentives?

Yes — KBLI 21013 is on the Tax Allowance priority list (PP 78/2019). Eligible for 30% reduction of taxable net income over 6 years plus accelerated depreciation.

Which authority issues the KBLI 21013 license?

Authority depends on the investor profile. For PMA: Minister/Head of Agency. For domestic SME scale: typically Governor (for Provincial scope) or Regent/Mayor (Regency/City scope). Specific mapping is in §1 of this page.

What other permits beyond the NIB does KBLI 21013 need?

Beyond the NIB, KBLI 21013 carries 5 PB UMKU permits across 2 sector regulators: Marine & Fisheries (3), Veterinary & Animal Medicine (2). Most operations only need 2-4 of these — the relevant set depends on which specific activities you actually perform; Emerhub maps the right subset before filing.

What KBLI codes are similar to 21013?

KBLIs in the same subgroup 2101: 21011 (Pharmaceutical Materials Industry for Humans); 21012 (Pharmaceutical Products Industry for Humans); 21014 (Pharmaceutical Industry for Animals); 21015 (Medical Devices Industry in Subgroup 2101). These are closely related activities — see the related-codes section below for full list.

What you’ll need to operate under KBLI 21013

Foreign investment rules

Open under BUPM (subject to sector rules)

Higher minimum capital required by BPOM / Kemenkes

Regulations governing KBLI 21013

How we handle your KBLI 21013 setup

Confirm the optimal structure for your business

Incorporate your PT PMA

Licensing requirements in detail

Application requirements

Ongoing obligations

Issuing authority

Auxiliary permits (PB UMKU)

Related codes in Pharmaceutical and Chemical Medicinal Product Industry

Get your KBLI 21013 setup handled end-to-end.

Open under BUPM — subject to sector regulator requirements.

What's specific to this sector

KBLI 21013 at a glance

What you’ll need to operate under KBLI 21013

Foreign investment rules

Open under BUPM (subject to sector rules)

Higher minimum capital required by BPOM / Kemenkes

Regulations governing KBLI 21013

How we handle your KBLI 21013 setup

Confirm the optimal structure for your business

Incorporate your PT PMA

Licensing requirements in detail

Application requirements

Ongoing obligations

Issuing authority

Auxiliary permits (PB UMKU)

Related codes in Pharmaceutical and Chemical Medicinal Product Industry

Get your KBLI 21013 setup handled end-to-end.

We obtain your NIB

Secure your Standard Certificate (Self-Declared)

Hand-off to ongoing compliance

Minister of Health Regulation No. 28 of 2022 on Changes in Classification, Restrictions, and Categories of Medicines

Minister of Health Regulation No. 10 of 2022 on the Classification and Reclassification of Psychotropic Substances

Minister of Health Regulation No. 9 of 2022 on Amendments to the Classification of Narcotics

Minister of Health Regulation No. 5 of 2022 on the Organization and Work Procedures of the Ministry of Health

Minister of Health Regulation No. 8 of 2022 on Amendments to Minister of Health Regulation No. 14 of 2021 on Business Activity and Product Standards in Risk-Based Licensing in the Health Sector

No. 6 of 2023

No. 127 of 2023

No. 188 of 2020

No. 30 of 2023

No. 5 of 2023

No. 10 of 2013

Law No. 33 of 2014 on Halal Product Assurance (UU JPH)

Minister of Health Regulation No. 36 of 2022 on Amendments to the Classification of Narcotics

Minister of Health Regulation No. 3 of 2021 on Changes in Classification, Restrictions, and Categories of Drugs

Minister of Health Regulation No. 4 of 2021 on Amendments to the Classification of Narcotics

What is KBLI 21013?

Who needs KBLI 21013?

Why does the code matter?

Under the upcoming KBLI 2025

Carried forward into KBLI 2025

Risk level by business scale

Micro

Small

Medium

Large

Common questions about KBLI 21013

What is KBLI 21013?

Can foreign investors operate under KBLI 21013?

What is the risk level of KBLI 21013?

What licenses does KBLI 21013 require?

What is the minimum capital for a PT PMA under KBLI 21013?

How long does it take to register a business under KBLI 21013?

Is KBLI 21013 eligible for Indonesian tax incentives?

Which authority issues the KBLI 21013 license?

What other permits beyond the NIB does KBLI 21013 need?

What KBLI codes are similar to 21013?